Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome
- PMID: 15231735
- PMCID: PMC443516
- DOI: 10.1101/gad.1199104
Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome
Erratum in
-
Corrigendum: Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome.Genes Dev. 2019 Apr 1;33(7-8):477. doi: 10.1101/gad.324970.119. Genes Dev. 2019. PMID: 30936192 Free PMC article. No abstract available.
Abstract
Tuberous sclerosis complex (TSC) and Peutz-Jeghers syndrome (PJS) are dominantly inherited benign tumor syndromes that share striking histopathological similarities. Here we show that LKB1, the gene mutated in PJS, acts as a tumor suppressor by activating TSC2, the gene mutated in TSC. Like TSC2, LKB1 inhibits the phosphorylation of the key translational regulators S6K and 4EBP1. Furthermore, we show that LKB1 activates TSC2 through the AMP-dependent protein kinase (AMPK), indicating that LKB1 plays a role in cell growth regulation in response to cellular energy levels. Our results suggest that PJS and other benign tumor syndromes could be caused by dysregulation of the TSC2/mTOR pathway.
Figures
![Figure 1.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/443516/bin/81531-04f1_1t.gif)
![Figure 2.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/443516/bin/81531-04f2_1t.gif)
![Figure 3.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/443516/bin/81531-04f3_1t.gif)
![Figure 4.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/443516/bin/81531-04f4_1t.gif)
![Figure 5.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/443516/bin/81531-04f5_1t.gif)
Similar articles
-
The LKB1 tumor suppressor negatively regulates mTOR signaling.Cancer Cell. 2004 Jul;6(1):91-9. doi: 10.1016/j.ccr.2004.06.007. Cancer Cell. 2004. PMID: 15261145
-
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling.Nat Cell Biol. 2002 Sep;4(9):648-57. doi: 10.1038/ncb839. Nat Cell Biol. 2002. PMID: 12172553
-
The tuberous sclerosis protein TSC2 is not required for the regulation of the mammalian target of rapamycin by amino acids and certain cellular stresses.J Biol Chem. 2005 May 13;280(19):18717-27. doi: 10.1074/jbc.M414499200. Epub 2005 Mar 16. J Biol Chem. 2005. PMID: 15772076
-
Dysregulation of HIF and VEGF is a unifying feature of the familial hamartoma syndromes.Cancer Cell. 2004 Jul;6(1):7-10. doi: 10.1016/j.ccr.2004.06.020. Cancer Cell. 2004. PMID: 15261137 Review.
-
The tuberous sclerosis complex genes in tumor development.Cancer Invest. 2004;22(4):588-603. doi: 10.1081/cnv-200027144. Cancer Invest. 2004. PMID: 15565817 Review.
Cited by
-
Clinical and Molecular Analysis in Patients with Peutz-Jeghers Syndrome.Turk J Gastroenterol. 2024 Mar 25;35(5):374-384. doi: 10.5152/tjg.2024.23262. Turk J Gastroenterol. 2024. PMID: 39115133 Free PMC article.
-
Concurrent loss of LKB1 and KEAP1 enhances SHMT-mediated antioxidant defence in KRAS-mutant lung cancer.Nat Metab. 2024 Jul;6(7):1310-1328. doi: 10.1038/s42255-024-01066-z. Epub 2024 Jun 14. Nat Metab. 2024. PMID: 38877143
-
Hydrogen peroxide modulates the expression of the target of rapamycin (TOR) and cell division in Arabidopsis thaliana.Protoplasma. 2024 May 28. doi: 10.1007/s00709-024-01959-6. Online ahead of print. Protoplasma. 2024. PMID: 38802622
-
Metabolic Roles of HIF1, c-Myc, and p53 in Glioma Cells.Metabolites. 2024 Apr 25;14(5):249. doi: 10.3390/metabo14050249. Metabolites. 2024. PMID: 38786726 Free PMC article. Review.
-
E4orf1: The triple agent of adenovirus - Unraveling its roles in oncogenesis, infectious obesity and immune responses in virus replication and vector therapy.Tumour Virus Res. 2024 Jun;17:200277. doi: 10.1016/j.tvr.2024.200277. Epub 2024 Feb 28. Tumour Virus Res. 2024. PMID: 38428735 Free PMC article. Review.
References
-
- Bardeesy N., Sinha, M., Hezel, A.F., Signoretti, S., Hathaway, N.A., Sharpless, N.E., Loda, M., Carrasco, D.R., and DePinho, R.A. 2002. Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation. Nature 419: 162-167. - PubMed
-
- Brugarolas J.B., Vazquez, F., Reddy, A., Sellers, W.R., and Kaelin Jr., W.G. 2003. TSC2 regulates VEGF through mTOR-dependent and -independent pathways. Cancer Cell 4: 147-158. - PubMed
-
- Dennis P.B., Jaeschke, A., Saitoh, M., Fowler, B., Kozma, S.C., and Thomas, G. 2001. Mammalian TOR: A homeostatic ATP sensor. Science 294: 1102-1105. - PubMed
-
- Devroede G., Lemieux, B., Masse, S., Lamarche, J., and Herman, P.S. 1988. Colonic hamartomas in tuberous sclerosis. Gastroenterology 94: 182-188. - PubMed
-
- El-Hashemite N., Walker, V., Zhang, H., and Kwiatkowski, D.J. 2003. Loss of Tsc1 or Tsc2 induces vascular endothelial growth factor production through mammalian target of rapamycin. Cancer Res. 63: 5173-5177. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous